| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study
|
Gargano, G.
|
|
|
18 |
S6 |
p. vi103-vi109
|
artikel
|
| 2 |
Adjuvant strategies in breast cancer: new prospectives, questions and reflections at the end of 2007 St Gallen International Expert Consensus Conference
|
Cinieri, S.
|
|
|
18 |
S6 |
p. vi63-vi65
|
artikel
|
| 3 |
Agreement between oncology guidelines and clinical practice in Italy: the ‘right’ program. A project of the Italian Association of Medical Oncology (AIOM)
|
Barni, S.
|
|
|
18 |
S6 |
p. vi179-vi184
|
artikel
|
| 4 |
Analysis of extended genomic rearrangements in oncological research
|
De Lellis, L.
|
|
|
18 |
S6 |
p. vi173-vi178
|
artikel
|
| 5 |
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett’s oesophagus
|
Agnese, V.
|
|
|
18 |
S6 |
p. vi110-vi115
|
artikel
|
| 6 |
author index
|
|
|
|
18 |
S6 |
p. vi197-vi198
|
artikel
|
| 7 |
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis
|
Campisi, G.
|
|
|
18 |
S6 |
p. vi168-vi172
|
artikel
|
| 8 |
breast cancer
|
|
|
|
18 |
S6 |
p. vi185-vi186
|
artikel
|
| 9 |
Cetuximab: clinical results in colorectal cancer
|
Maiello, E.
|
|
|
18 |
S6 |
p. vi8-vi10
|
artikel
|
| 10 |
Cetuximab in squamous cell head and neck carcinomas
|
Gebbia, V.
|
|
|
18 |
S6 |
p. vi5-vi7
|
artikel
|
| 11 |
Chemoradiotherapy as adjuvant treatment of gastric cancer
|
Orditura, M.
|
|
|
18 |
S6 |
p. vi133-vi135
|
artikel
|
| 12 |
Clinical and therapeutic perspectives of gene expression profiling for breast cancer
|
Chiuri, V.E.
|
|
|
18 |
S6 |
p. vi58-vi62
|
artikel
|
| 13 |
Dasatinib: a new step in molecular target therapy
|
Olivieri, A.
|
|
|
18 |
S6 |
p. vi42-vi46
|
artikel
|
| 14 |
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily)
|
Russo, A.
|
|
|
18 |
S6 |
p. vi99-vi102
|
artikel
|
| 15 |
Emotional expression and coping style in female breast cancer
|
Manna, G.
|
|
|
18 |
S6 |
p. vi77-vi80
|
artikel
|
| 16 |
Erlotinib in cancer treatment
|
Bareschino, M.A.
|
|
|
18 |
S6 |
p. vi35-vi41
|
artikel
|
| 17 |
Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1α in human colorectal cancer
|
Koda, M.
|
|
|
18 |
S6 |
p. vi116-vi119
|
artikel
|
| 18 |
Founder mutations in BRCA1 and BRCA2 genes
|
Ferla, R.
|
|
|
18 |
S6 |
p. vi93-vi98
|
artikel
|
| 19 |
From the trastuzumab era to new target therapies: beyond revolution
|
Barni, S.
|
|
|
18 |
S6 |
p. vi1-vi4
|
artikel
|
| 20 |
gastrointestinal cancer
|
|
|
|
18 |
S6 |
p. vi188-vi190
|
artikel
|
| 21 |
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features
|
Badalamenti, G.
|
|
|
18 |
S6 |
p. vi136-vi140
|
artikel
|
| 22 |
head and neck cancer
|
|
|
|
18 |
S6 |
p. vi191
|
artikel
|
| 23 |
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability
|
Veschi, S.
|
|
|
18 |
S6 |
p. vi86-vi92
|
artikel
|
| 24 |
Immunotherapy for metastatic renal cell carcinoma: is it a therapeutic option yet?
|
Guida, M.
|
|
|
18 |
S6 |
p. vi149-vi152
|
artikel
|
| 25 |
Integrated therapy of kidney cancer
|
Longo, R.
|
|
|
18 |
S6 |
p. vi141-vi148
|
artikel
|
| 26 |
Lapatinib in breast cancer
|
Bilancia, D.
|
|
|
18 |
S6 |
p. vi26-vi30
|
artikel
|
| 27 |
Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study
|
Giotta, F.
|
|
|
18 |
S6 |
p. vi66-vi69
|
artikel
|
| 28 |
Management of advanced breast cancer
|
Orlando, L.
|
|
|
18 |
S6 |
p. vi74-vi76
|
artikel
|
| 29 |
melanoma
|
|
|
|
18 |
S6 |
p. vi192
|
artikel
|
| 30 |
miscellaneous cancer
|
|
|
|
18 |
S6 |
p. vi193-vi196
|
artikel
|
| 31 |
Neo-adjuvant and adjuvant chemotherapy in bladder cancer
|
D'Auria, G.
|
|
|
18 |
S6 |
p. vi162-vi163
|
artikel
|
| 32 |
Neo-adjuvant and adjuvant chemotherapy of gastric cancer
|
De Vita, F.
|
|
|
18 |
S6 |
p. vi120-vi123
|
artikel
|
| 33 |
New developments of aminobisphosphonates: the double face of Janus
|
Santini, D.
|
|
|
18 |
S6 |
p. vi164-vi167
|
artikel
|
| 34 |
ovarian and prostate cancer
|
|
|
|
18 |
S6 |
p. vi187
|
artikel
|
| 35 |
Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients
|
Adamo, V.
|
|
|
18 |
S6 |
p. vi53-vi57
|
artikel
|
| 36 |
Panitumumab a novel drug in cancer treatment
|
Cartenì, G.
|
|
|
18 |
S6 |
p. vi16-vi21
|
artikel
|
| 37 |
Protein kinase inhibitors in the treatment of renal cell carcinoma: sorafenib
|
Bracarda, S.
|
|
|
18 |
S6 |
p. vi22-vi25
|
artikel
|
| 38 |
Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study
|
Rosati, G.
|
|
|
18 |
S6 |
p. vi128-vi132
|
artikel
|
| 39 |
Role of external radiation therapy in urinary cancers
|
Parisi, S.
|
|
|
18 |
S6 |
p. vi157-vi161
|
artikel
|
| 40 |
Role of liposomal anthracyclines in breast cancer
|
Lorusso, V.
|
|
|
18 |
S6 |
p. vi70-vi73
|
artikel
|
| 41 |
Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study)
|
Adamo, V.
|
|
|
18 |
S6 |
p. vi11-vi15
|
artikel
|
| 42 |
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice
|
Gebbia, V.
|
|
|
18 |
S6 |
p. vi124-vi127
|
artikel
|
| 43 |
Sunitinib: bridging present and future cancer treatment
|
Grimaldi, A.M.
|
|
|
18 |
S6 |
p. vi31-vi34
|
artikel
|
| 44 |
Table of Contents
|
|
|
|
18 |
S6 |
p. iv-v
|
artikel
|
| 45 |
The estrogen receptor α:insulin receptor substrate 1 complex in breast cancer: structure–function relationships
|
Sisci, D.
|
|
|
18 |
S6 |
p. vi81-vi85
|
artikel
|
| 46 |
Therapy of metastatic bladder carcinoma
|
Iaffaioli, R.V.
|
|
|
18 |
S6 |
p. vi153-vi156
|
artikel
|
| 47 |
The role of Aurora-A inhibitors in cancer therapy
|
Agnese, V.
|
|
|
18 |
S6 |
p. vi47-vi52
|
artikel
|
Tijdschrift beschrijving